Expand ACRV Menu

ACRV Stock Summary and Trading Ideas (Acrivon Therapeutics | NASDAQ:ACRV)

Charts for Today's Stock Price and Implied Volatility in Acrivon Therapeutics


Stock Price & Volume | Full Chart


Trading Statistics

Key Ratios

Acrivon Therapeutics (ACRV) Frequently Asked Questions

What does Acrivon Therapeutics do?

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Company matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

What symbol and exchange does Acrivon Therapeutics stock trade?

Acrivon Therapeutics trades on the NASDAQ stock market under the symbol ACRV.

What is Acrivon Therapeutics stock price doing today?

As of March 20, 2023, ACRV stock price declined to $11.61 with 202,129 million shares trading.

How much is Acrivon Therapeutics worth?

ACRV has a market cap of $242.47 million. This is considered a Small Cap stock.

What are the top ETFs holding Acrivon Therapeutics?

The top ETF exchange traded funds that ACRV belongs to (by Net Assets): IWM, IWN, IWO, IWC.

What is the support and resistance for Acrivon Therapeutics (ACRV) stock price?

ACRV support price is $17.76 and resistance is $22.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACRV stock will trade within this expected range on the day.